ARCT Financial Statements

Balance sheet, income statement, cash flow, and dividends for Arcturus Therapeutics Holdings Inc (ARCT).


$459.67M Market Cap.

As of 03/06/2025 5:00 PM ET (MRY) • Disclaimer

ARCT Market Cap. (MRY)


ARCT Shares Outstanding (MRY)


ARCT Assets (MRY)


Total Assets

$344.07M

Total Liabilities

$103.09M

Total Investments

$1.89M

ARCT Income (MRY)


Revenue

$152.31M

Net Income

-$80.94M

Operating Expense

$247.98M

ARCT Cash Flow (MRY)


CF Operations

-$59.75M

CF Investing

-$648.00K

CF Financing

$5.42M

ARCT Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

ARCT Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$344,069,000 (-19.87%)

$429,402,000 (-4.66%)

$450,387,000 (14.66%)

$392,814,000 (-17.56%)

Assets Current

$305,979,000 (-20.85%)

$386,590,000 (-4.15%)

$403,333,000 (6.43%)

$378,961,000 (-18.99%)

Assets Non-Current

$38,090,000 (-11.03%)

$42,812,000 (-9.02%)

$47,054,000 (239.67%)

$13,853,000 (59.84%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$240,978,000 (-13.48%)

$278,513,000 (3.03%)

$270,312,000 (18.45%)

$228,211,000 (-42.45%)

Property Plant & Equipment Net

$36,205,000 (-11.54%)

$40,927,000 (-8.97%)

$44,960,000 (299.25%)

$11,261,000 (31.55%)

Cash & Equivalents

$292,028,000 (-15.84%)

$347,005,000 (-11.45%)

$391,883,000 (5.77%)

$370,492,000 (-19.96%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$32,118,000 (-63.22%)

$87,325,000 (79.24%)

$48,719,000 (-23.17%)

$63,413,000 (107.10%)

Total Investments

$1,885,000 (0.00%)

$1,885,000 (-9.98%)

$2,094,000 (-19.21%)

$2,592,000 (2322.43%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$1,885,000 (0.00%)

$1,885,000 (-9.98%)

$2,094,000 (-19.21%)

$2,592,000 (2322.43%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$3,974,000 (-87.61%)

$32,064,000 (1060.06%)

$2,764,000 (-17.91%)

$3,367,000 (58.45%)

Trade & Non-Trade Payables

$7,194,000 (36.28%)

$5,279,000 (-29.13%)

$7,449,000 (-25.94%)

$10,058,000 (-6.65%)

Accumulated Retained Earnings (Deficit)

-$448,807,000 (-22.00%)

-$367,866,000 (-8.79%)

-$338,141,000 (2.69%)

-$347,490,000 (-141.62%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$24,998,000 (-3.51%)

$25,907,000 (-71.49%)

$90,871,000 (34.41%)

$67,609,000 (253.60%)

Debt Current

$0 (0%)

$0 (0%)

$60,655,000 (169.89%)

$22,474,000 (1697.92%)

Debt Non-Current

$24,998,000 (-3.51%)

$25,907,000 (-14.26%)

$30,216,000 (-33.05%)

$45,135,000 (152.57%)

Total Liabilities

$103,091,000 (-31.68%)

$150,889,000 (-16.21%)

$180,075,000 (9.40%)

$164,603,000 (106.00%)

Liabilities Current

$65,489,000 (-20.12%)

$81,989,000 (-35.43%)

$126,984,000 (27.57%)

$99,537,000 (101.00%)

Liabilities Non-Current

$37,602,000 (-45.43%)

$68,900,000 (29.78%)

$53,091,000 (-18.40%)

$65,066,000 (114.16%)

ARCT Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$152,310,000 (-8.69%)

$166,799,000 (-19.03%)

$205,999,000 (1566.79%)

$12,359,000 (29.56%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$52,823,000 (-0.09%)

$52,871,000 (14.76%)

$46,071,000 (11.15%)

$41,451,000 (78.54%)

Research & Development Expense

$195,156,000 (1.57%)

$192,133,000 (30.04%)

$147,751,000 (-14.97%)

$173,760,000 (200.38%)

Operating Expenses

$247,979,000 (1.21%)

$245,004,000 (26.41%)

$193,822,000 (-9.94%)

$215,211,000 (165.49%)

Interest Expense

-$15,195,000 (8.41%)

-$16,591,000 (-4050.24%)

$420,000 (-78.14%)

$1,921,000 (432.13%)

Income Tax Expense

-$4,000 (-100.22%)

$1,835,000 (41.70%)

$1,295,000 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$80,941,000 (-172.30%)

-$29,725,000 (-417.95%)

$9,349,000 (104.59%)

-$203,674,000 (-182.30%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$80,941,000 (-172.30%)

-$29,725,000 (-417.95%)

$9,349,000 (104.59%)

-$203,674,000 (-182.30%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$80,941,000 (-172.30%)

-$29,725,000 (-417.95%)

$9,349,000 (104.59%)

-$203,674,000 (-182.30%)

Weighted Average Shares

$27,000,000 (1.40%)

$26,628,000 (0.69%)

$26,445,000 (0.49%)

$26,317,000 (29.61%)

Weighted Average Shares Diluted

$27,000,000 (1.40%)

$26,628,000 (-1.72%)

$27,093,000 (2.95%)

$26,317,000 (29.61%)

Earning Before Interest & Taxes (EBIT)

-$96,140,000 (-116.14%)

-$44,481,000 (-502.03%)

$11,064,000 (105.48%)

-$201,753,000 (-181.04%)

Gross Profit

$152,310,000 (-8.69%)

$166,799,000 (-19.03%)

$205,999,000 (1566.79%)

$12,359,000 (29.56%)

Operating Income

-$95,669,000 (-22.33%)

-$78,205,000 (-742.24%)

$12,177,000 (106.00%)

-$202,852,000 (-183.61%)

ARCT Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$648,000 (77.66%)

-$2,901,000 (62.45%)

-$7,726,000 (-126.83%)

-$3,406,000 (-95.52%)

Net Cash Flow from Financing

$5,418,000 (122.49%)

-$24,087,000 (-742.50%)

-$2,859,000 (-105.95%)

$48,016,000 (-88.99%)

Net Cash Flow from Operations

-$59,747,000 (-230.11%)

-$18,099,000 (-156.57%)

$31,993,000 (123.69%)

-$135,043,000 (-215.07%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$54,977,000 (-21.94%)

-$45,087,000 (-310.61%)

$21,408,000 (123.67%)

-$90,433,000 (-123.10%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

-$648,000 (77.66%)

-$2,901,000 (62.45%)

-$7,726,000 (-126.83%)

-$3,406,000 (-95.52%)

Issuance (Repayment) of Debt Securities

$0 (0%)

-$27,364,000 (-447.28%)

-$5,000,000 (-110.73%)

$46,599,000 (0%)

Issuance (Purchase) of Equity Shares

$5,418,000 (65.33%)

$3,277,000 (53.06%)

$2,141,000 (51.09%)

$1,417,000 (-99.68%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$37,988,000 (9.64%)

$34,649,000 (13.19%)

$30,611,000 (5.87%)

$28,915,000 (327.48%)

Depreciation Amortization & Accretion

$3,544,000 (19.85%)

$2,957,000 (93.65%)

$1,527,000 (28.00%)

$1,193,000 (35.26%)

ARCT Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

100.00% (0.00%)

100.00% (0.00%)

100.00% (0.00%)

100.00% (0.00%)

Profit Margin

-53.10% (-198.31%)

-17.80% (-495.56%)

4.50% (100.27%)

-1648.00% (-117.90%)

EBITDA Margin

-60.80% (-144.18%)

-24.90% (-508.20%)

6.10% (100.38%)

-1622.80% (-118.32%)

Return on Average Equity (ROAE)

-31.60% (-212.87%)

-10.10% (-310.42%)

4.80% (106.75%)

-71.10% (-89.60%)

Return on Average Assets (ROAA)

-21.30% (-222.73%)

-6.60% (-353.85%)

2.60% (105.60%)

-46.40% (-63.96%)

Return on Sales (ROS)

-63.10% (-136.33%)

-26.70% (-594.44%)

5.40% (100.33%)

-1632.40% (-116.90%)

Return on Invested Capital (ROIC)

-899.50% (-750.99%)

-105.70% (-414.58%)

33.60% (-98.81%)

2819.90% (205.52%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-5.66 (79.91%)

-28.15 (-158.10%)

48.46 (1113.32%)

-4.78 (60.87%)

Price to Sales Ratio (P/S)

3.01 (-40.23%)

5.03 (131.19%)

2.18 (-97.24%)

78.81 (-14.65%)

Price to Book Ratio (P/B)

1.91 (-36.93%)

3.02 (82.01%)

1.66 (-61.12%)

4.28 (59.57%)

Debt to Equity Ratio (D/E)

0.43 (-21.03%)

0.54 (-18.62%)

0.67 (-7.63%)

0.72 (258.71%)

Earnings Per Share (EPS)

-3 (-167.86%)

-1.12 (-420.00%)

0.35 (104.52%)

-7.74 (-118.03%)

Sales Per Share (SPS)

5.64 (-9.95%)

6.26 (-19.59%)

7.79 (1557.45%)

0.47 (0.00%)

Free Cash Flow Per Share (FCFPS)

-2.24 (-183.52%)

-0.79 (-185.95%)

0.92 (117.45%)

-5.26 (-139.46%)

Book Value Per Share (BVPS)

8.93 (-14.67%)

10.46 (2.32%)

10.22 (17.87%)

8.67 (-55.60%)

Tangible Assets Book Value Per Share (TABVPS)

12.74 (-20.98%)

16.13 (-5.31%)

17.03 (14.10%)

14.93 (-36.39%)

Enterprise Value Over EBIT (EV/EBIT)

-2 (83.33%)

-12 (-144.44%)

27 (1000.00%)

-3 (72.73%)

Enterprise Value Over EBITDA (EV/EBITDA)

-2.09 (84.01%)

-13.07 (-154.38%)

24.03 (891.34%)

-3.04 (72.20%)

Asset Turnover

0.4 (7.24%)

0.37 (-35.58%)

0.58 (1967.86%)

0.03 (-24.32%)

Current Ratio

4.67 (-0.91%)

4.71 (48.46%)

3.18 (-16.57%)

3.81 (-59.70%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$60,395,000 (-187.60%)

-$21,000,000 (-186.54%)

$24,267,000 (117.53%)

-$138,449,000 (-210.40%)

Enterprise Value (EV)

$193,481,482 (-64.35%)

$542,686,658 (79.34%)

$302,601,058 (-50.31%)

$609,002,882 (-21.39%)

Earnings Before Tax (EBT)

-$80,945,000 (-190.23%)

-$27,890,000 (-362.03%)

$10,644,000 (105.23%)

-$203,674,000 (-182.30%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$92,596,000 (-122.99%)

-$41,524,000 (-429.79%)

$12,591,000 (106.28%)

-$200,560,000 (-182.86%)

Invested Capital

$11,550,000 (-56.11%)

$26,315,000 (17.52%)

$22,391,000 (333.09%)

-$9,606,000 (42.96%)

Working Capital

$240,490,000 (-21.05%)

$304,601,000 (10.22%)

$276,349,000 (-1.10%)

$279,424,000 (-33.19%)

Tangible Asset Value

$344,069,000 (-19.87%)

$429,402,000 (-4.66%)

$450,387,000 (14.66%)

$392,814,000 (-17.56%)

Market Capitalization

$459,672,482 (-45.45%)

$842,586,658 (87.53%)

$449,319,058 (-53.94%)

$975,602,882 (-8.18%)

Average Equity

$256,349,750 (-12.58%)

$293,249,500 (52.05%)

$192,861,250 (-32.66%)

$286,398,000 (49.05%)

Average Assets

$380,545,000 (-14.89%)

$447,140,250 (25.69%)

$355,754,000 (-19.04%)

$439,407,750 (72.15%)

Invested Capital Average

$10,687,750 (-74.60%)

$42,077,000 (27.73%)

$32,942,250 (560.44%)

-$7,154,500 (-366.34%)

Shares

27,087,359 (1.36%)

26,723,332 (0.87%)

26,492,869 (0.50%)

26,360,521 (7.62%)